These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 11233517)

  • 41. Treatment of chronic viral hepatitis.
    Ferenci P
    Best Pract Res Clin Gastroenterol; 2004; 18 Suppl():113-20. PubMed ID: 15588803
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Higher efficacy of sequential therapy with interferon-alpha and lamivudine combination compared to lamivudine monotherapy in HBeAg positive chronic hepatitis B patients.
    Sarin SK; Kumar M; Kumar R; Kazim SN; Guptan RC; Sakhuja P; Sharma BC
    Am J Gastroenterol; 2005 Nov; 100(11):2463-71. PubMed ID: 16279901
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A randomized double-blind placebo-controlled study of lamivudine in the treatment of patients with chronic hepatitis B virus infection.
    Yao G; Wang B; Cui Z; Yao J; Zeng M
    Chin Med J (Engl); 1999 May; 112(5):387-91. PubMed ID: 11593504
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Pretreatment ALT level and histologic activity as predictors of HBeAg loss in lamivudine treatment for chronic hepatitis B].
    Kweon YO; Kang KH
    Korean J Hepatol; 2004 Mar; 10(1):31-41. PubMed ID: 15096715
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Long-term experience with lamivudine therapy for hepatitis B virus infection after liver transplantation.
    Ben-Ari Z; Mor E; Shapira Z; Tur-Kaspa R
    Liver Transpl; 2001 Feb; 7(2):113-7. PubMed ID: 11172394
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Telbivudine versus lamivudine in Chinese patients with chronic hepatitis B: Results at 1 year of a randomized, double-blind trial.
    Hou J; Yin YK; Xu D; Tan D; Niu J; Zhou X; Wang Y; Zhu L; He Y; Ren H; Wan M; Chen C; Wu S; Chen Y; Xu J; Wang Q; Wei L; Chao G; Constance BF; Harb G; Brown NA; Jia J
    Hepatology; 2008 Feb; 47(2):447-54. PubMed ID: 18080339
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Predictors of hepatitis B e antigen-negative hepatitis in chronic hepatitis B virus-infected patients from childhood to adulthood.
    Wu JF; Chiu YC; Chang KC; Chen HL; Ni YH; Hsu HY; Chang MH
    Hepatology; 2016 Jan; 63(1):74-82. PubMed ID: 26389515
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Sequential treatment with lamivudine and interferon monotherapies in patients with chronic hepatitis B not responding to interferon alone: results of a pilot study.
    Serfaty L; Thabut D; Zoulim F; Andreani T; Chazouillères O; Carbonell N; Loria A; Poupon R
    Hepatology; 2001 Sep; 34(3):573-7. PubMed ID: 11526544
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Clinical efficacy of lamivudine in the treatment of chronic hepatitis B].
    Ma H; You H; Yin S
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2001 Jun; 15(2):147-9. PubMed ID: 11436644
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Long-term effect of lamivudine treatment in chronic hepatitis B virus infection].
    Yao G; Wang B; Cui Z
    Zhonghua Gan Zang Bing Za Zhi; 1999 Jun; 7(2):80-3. PubMed ID: 10488413
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Entecavir therapy for up to 96 weeks in patients with HBeAg-positive chronic hepatitis B.
    Gish RG; Lok AS; Chang TT; de Man RA; Gadano A; Sollano J; Han KH; Chao YC; Lee SD; Harris M; Yang J; Colonno R; Brett-Smith H
    Gastroenterology; 2007 Nov; 133(5):1437-44. PubMed ID: 17983800
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Economic evaluation of lamivudine compared with interferon-alpha in the treatment of chronic hepatitis B in the United States.
    Brooks EA; Lacey LF; Payne SL; Miller DW
    Am J Manag Care; 2001 Jul; 7(7):677-82. PubMed ID: 11464426
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Identification of factors associated with YMDD mutation in patients with chronic hepatitis B receiving lamivudine treatment].
    Cao XX; Li J; Qiu LM; Luo YW; Chen YH; Ran Y
    Zhonghua Gan Zang Bing Za Zhi; 2009 Sep; 17(9):641-4. PubMed ID: 19785947
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Association of core promoter mutations with viral breakthrough in chronic hepatitis B patients on long-term lamivudine therapy.
    Kazim SN; Chauhan R; Das BC; Sarin SK
    J Gastroenterol Hepatol; 2006 Oct; 21(10):1525-32. PubMed ID: 16928212
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [A long-term observation and follow-up for patients with HBeAg/Anti-HBe seroconversion after lamivudine treatment].
    Wu JL; Li SG; Wen FY; Yang XY; Zhou HJ
    Zhonghua Gan Zang Bing Za Zhi; 2005 Apr; 13(4):297-9. PubMed ID: 15850522
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Randomized comparison of tenofovir disoproxil fumarate vs emtricitabine and tenofovir disoproxil fumarate in patients with lamivudine-resistant chronic hepatitis B.
    Fung S; Kwan P; Fabri M; Horban A; Pelemis M; Hann HW; Gurel S; Caruntu FA; Flaherty JF; Massetto B; Dinh P; Corsa A; Subramanian GM; McHutchison JG; Husa P; Gane E
    Gastroenterology; 2014 Apr; 146(4):980-8. PubMed ID: 24368224
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [A study on the clinical and pathological efficacy of lamivudine in the treatment of chronic hepatitis B].
    Yang C; Xiao YH; Guan XQ; Yuan Z
    Zhonghua Gan Zang Bing Za Zhi; 2004 Jun; 12(6):364-7. PubMed ID: 15225436
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Therapeutic efficacy of sequential and simultaneous treatments with interferon-alpha and lamivudine in children with chronic hepatitis B.
    Akman SA; Okcu SC; Halicioğlu O; Sutcuoglu S; Anil M; Kizilgunesler A; Bakiler AR
    Pediatr Int; 2007 Dec; 49(6):848-52. PubMed ID: 18045284
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Lamivudine for hepatitis B in clinical practice.
    Schiff ER
    J Med Virol; 2000 Jul; 61(3):386-91. PubMed ID: 10861651
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [The clinical meaning of the emergence of viral breakthrough during lamivudine treatment in patients with hepatitis B virus related chronic liver disease].
    Park CB; Lim HJ; Yun BC; Lee SU; Han BH
    Korean J Hepatol; 2004 Jun; 10(2):108-16. PubMed ID: 15218344
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.